(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Grand Hyatt Washington at Washington Center

Feb 20, 2013 8:00 AM - Feb 21, 2013 5:00 PM

1000 H Street, NW, , Washington, DC 20001-4310 , USA

Marketing Pharmaceuticals 2013: Workshop for Regulatory, Legal, Communications Professionals, and Promotional Review Teams

Back to Agenda

Product Communications in the Pre-Approval Phase

Session Chair(s)

Mark Gaydos

Mark Gaydos

Global Head, Advertising & Promotion, Global Regulatory Affairs

Sanofi, United States

This session will focus on the types of information a company might consider communicating about its research efforts, pipeline products and corresponding development programs. Select topics include: What, how, and to whom can companies communicate about research efforts and pipeline products while avoiding allegations of pre-approval or off-label promotion? What and when can a company proactively communicate about planned and ongoing clinical trials? What are the parameters a company should observe when developing a pre-approval disease awareness campaign? What are the pros and cons of a coming soon campaign?

Speaker(s)

Leah Palmer, PharmD

Speakers

Leah Palmer, PharmD

United States

Consultant, Regulatory Promotion

Dennis Lawrence Nosco, PhD, RAC

Speakers

Dennis Lawrence Nosco, PhD, RAC

Mallinckrodt, United States

Senior Director, Global Labeling, Regulatory Affairs

Alan R Bennett, JD

Speakers

Alan R Bennett, JD

Ropes & Gray, United States

Senior Counsel

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.